https://www.selleckchem.com/pr....oducts/acetalax-oxyp
eening. Irritable bowel syndrome (IBS) is a pathologic condition characterized by changes in gut microbiome composition, low-grade inflammation, and disruption of intestinal wall permeability. The interaction between the gut microbiome and the disease manifestation remains unclear. The changing of tight junction proteins and cytokines expression throughout the gastrointestinal tract in IBS patients has not been studied yet. To assess the changes of gut microbiome composition, tight junction proteins, and cytokines
Like
Comment
Share
